We are monitoring the impact of COVID-19 on North America Plasma Fractionation Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 2720
Share on
Share on

North America Plasma Fractionation Market Research Report – Segmented By Product, Application, End User & Country (the United States, Canada and Rest of North America) - Industry Analysis on Size, Share, Trends, COVId-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 2720
Pages: 145

North America Plasma Fractionation Market Size (2021 to 2026)

The size of the Plasma Fractionation Market in North America was worth USD 7.00 billion in 2021. This value is forecasted to be growing at a CAGR of 8.3% and value USD 10.42 billion by 2026. Increasing the use of immunoglobulins in several therapeutic areas, increasing the aged population, and the rise in prevalence of rare diseases are primarily driving the growth of the North American plasma fractionation market. 

Plasma Fractionation consists of the fractionation of blood into its constituent parts of red cells, white cells, and platelets suspended in plasma. The plasma is studied for deficiencies relating to blood disorders and replaced or supplemented with a cure.

Plasma, which constitutes about 55% of blood by volume, consists of several different proteins numbering into the thousands and other substances like minerals, hormones, etc. There are many therapeutic uses for the proteins present in plasma. For example, Albumin is commonly used to rejuvenate and maintain blood volume after traumatic injury, surgery, and plasma exchange.

Increasing the use of immunoglobulins, antibodies, the rising incidence of immune and bleeding disorders, the growing occurrence of Alpha-1 Antitrypsin deficiency, and the aging population prone to blood-related ailments are key factors driving the market.

However, adversarial reactions to the procedure of plasma fractionation and transfer, high costs of plasma products, and unfavorable reimbursement policies are the main constraints of market growth.

This research report on North America Plasma Fractionation Market has been segmented and sub-segmented into the following categories:

By Product: 

  • Albumin
  • Immunoglobulin
  • Factor VIII
  • Protease Inhibitors

By Application: 

  • Neurology
  • Hematology
  • Rheumatology
  • Pulmonology
  • Immunology

By End User: 

  • Hospitals
  • Clinical Laboratories

By Country: 

  • The United States
  • Canada
  • Rest of North America

Based on the region, the North American plasma fractionation market accounted for a significant chunk of the global share in 2020. The U.S. accounted for a considerable share in the North American market. Swift introduction of new blood-related procedures driven by the increasing incidence of blood disorders due to the growing population age drives the North American plasma fractionation market.

The U.S. Plasma Fractionation Market is estimated to occupy a significant share in the North American market during the forecast period due to technological advancements, favorable reimbursement policies, and a high standard of living that have led to increased life expectancy. The growing geriatric population in the United States is expected to drive the market because aging is considered the top risk factor for developing cardiovascular and neurological diseases in aged people. In the United States, the population age 60 and more numbered 49.2 million in 2016, representing 15.2% of the population, about one in every seven Americans. The increasing number of plasma collection centers across the United States is expected to help the market's growth. According to FDA data in the United States, there are 805 plasma donation centers. The cases of COPD are likely to increase in the United States due to substantial smoking prevalence and geriatric populations. Moreover, according to the American Academy of Allergy, Asthma & Immunology, in 2016, around 8.3% of children in the United States had asthma disease. Asthma is the most common chronic disease found in American children.

KEY MARKET PLAYERS:

A few of the prominent companies operating in the North American plasma fractionation market profiled in the report are CSL Ltd. (Australia), Grifols S.A (Spain), Baxalta Incorporated (U.S.), Octapharma AG (Switzerland), Kedrion S.p.A (Italy), Bio Products Laboratory (U.K.), Sanquin (Netherland), China Biologic Products, Inc. (China), Biotest AG (Germany), and Laboratoire Français du Fractionnement et des Biotechnologies (France).

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Fractionation Process         

                                5.1.3 Immunoglobulin   

                                5.1.4 Coagulation Factor Concentrates  

                                5.1.5 Albumin   

                                5.1.6 Protease Inhibitors              

                                5.1.7  Y-o-Y Growth Analysis, By Product              

                                5.1.8  Market Attractiveness Analysis, By Product            

                                5.1.9  Market Share Analysis, By Product              

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Neurology               

                                5.2.3 Immunology           

                                5.2.4 Hematology            

                                5.2.5 Critical Care             

                                5.2.6 Pulmonology          

                                5.2.7 Hemato-Oncology               

                                5.2.8 Rheumatology       

                                5.2.9 Other Application 

                                5.2.10 Y-o-Y Growth Analysis, By Application      

                                5.2.11 Market Attractiveness Analysis, By Application    

                                5.2.12 Market Share Analysis, By Application      

                5.3 End User                      

                                5.4.1 Introduction           

                                5.4.2 Hospitals  

                                5.4.3 Clinical Laboratories            

                                5.4.4 Academic Institutes            

                                5.4.5 Y-o-Y Growth Analysis, By End User             

                                5.4.6  Market Attractiveness Analysis, By End User          

                                5.4.7  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By Application

                                                6.1.3.4 By Indication

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By Application

                                                6.1.4.4 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By Application

                                                6.1.5.4 By End User

                6.2 United States                            

                6.3 Canada                         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Baxalta Incorporated                              

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 CSL Ltd.                        

                8.3 Grifols S.A                   

                8.4 Octapharma AG                        

                8.5 Kedrion S.p.A                            

                8.6 Bio Products Laboratory                        

                8.7 Sanquin                        

                8.8 China Biologic Products, Inc.                

                8.9 Biotest AG                  

                8.10 Laboratoire Français du Fractionnement et des Biotechnologies                      

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Plasma Fractionation Market, By Product, From 2021 to 2026 (USD Million)
  2. North America Immunoglobulin Market, By Region, From 2021 to 2026 (USD Million)
  3. North America Coagulation Factor Concentrates Market, By Region, From 2021 to 2026 (USD Million)
  4. North America Albumin Market, By Region, From 2021 to 2026 (USD Million)
  5. North America Protease Inhibitors Market, By Region, From 2021 to 2026 (USD Million)
  6. North America Other Plasma Products Market, By Region, From 2021 to 2026 (USD Million)
  7. North America Plasma Fractionation Market, By Application, From 2021 to 2026 (USD Million)
  8. North America Neurology Market, By Region, From 2021 to 2026 (USD Million)
  9. North America Immunology Market, By Region, From 2021 to 2026 (USD Million)
  10. North America Hematology Market, By Region, From 2021 to 2026 (USD Million)
  11. North America Critical Care Market, By Region, From 2021 to 2026 (USD Million)
  12. North America Pulmonology Market, By Region, From 2021 to 2026 (USD Million)
  13. North America Hemato-oncology Market, By Region, From 2021 to 2026 (USD Million)
  14. North America Rheumatology Market, By Region, From 2021 to 2026 (USD Million)
  15. North America Other Applications Market, By Region, From 2021 to 2026 (USD Million)
  16. North America Plasma Fractionation Market, By By End User, From 2021 to 2026 (USD Million)
  17. North America Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  18. North America Clinical Laboratories Market, By Region, From 2021 to 2026 (USD Million)
  19. North America Academic Institutes Market, By Region, From 2021 to 2026 (USD Million)
  20. United States Plasma Fractionation Market, By Product, From 2021 to 2026 (USD Million)
  21. United States Plasma Fractionation Market, By Application, From 2021 to 2026 (USD Million)
  22. United States Plasma Fractionation Market, By By End User, From 2021 to 2026 (USD Million)
  23. Canada Plasma Fractionation Market, By Product, From 2021 to 2026 (USD Million)
  24. Canada Plasma Fractionation Market, By Application, From 2021 to 2026 (USD Million)
  25. Canada Plasma Fractionation Market, By By End User, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample